State Release 186
Guidance for : Revision to the Line Extension Unit Rebate Amount Calculation Effective January 1, 2010, the Affordable Care Act established a different rebate amount calculation under section 1927 of the Social Security Act (the Act) for new oral solid dosage formulations (line extensions) of brand name drugs. However, the original statutory language omitted an important component of the calculation, which was subsequently revised under the Bipartisan Budget Act (BBA) of 2018
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: August 09, 2018
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.